DK1709075T3 - Behandling af virusinfektioner - Google Patents

Behandling af virusinfektioner

Info

Publication number
DK1709075T3
DK1709075T3 DK04806160.0T DK04806160T DK1709075T3 DK 1709075 T3 DK1709075 T3 DK 1709075T3 DK 04806160 T DK04806160 T DK 04806160T DK 1709075 T3 DK1709075 T3 DK 1709075T3
Authority
DK
Denmark
Prior art keywords
treatment
virus infections
infections
virus
Prior art date
Application number
DK04806160.0T
Other languages
English (en)
Inventor
Curtis Dobson
Original Assignee
Ai2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai2 Ltd filed Critical Ai2 Ltd
Application granted granted Critical
Publication of DK1709075T3 publication Critical patent/DK1709075T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK04806160.0T 2003-12-17 2004-12-17 Behandling af virusinfektioner DK1709075T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329254.7A GB0329254D0 (en) 2003-12-17 2003-12-17 Treatment of viral infections
PCT/GB2004/005360 WO2005058959A2 (en) 2003-12-17 2004-12-17 Treatment of viral infections

Publications (1)

Publication Number Publication Date
DK1709075T3 true DK1709075T3 (da) 2012-08-27

Family

ID=30471239

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04806160.0T DK1709075T3 (da) 2003-12-17 2004-12-17 Behandling af virusinfektioner

Country Status (11)

Country Link
US (3) US7691382B2 (da)
EP (2) EP1709075B9 (da)
JP (2) JP2007535910A (da)
CN (2) CN1894281B (da)
AU (1) AU2004299343B8 (da)
CA (1) CA2548585A1 (da)
DK (1) DK1709075T3 (da)
ES (1) ES2389078T3 (da)
GB (1) GB0329254D0 (da)
PL (1) PL1709075T3 (da)
WO (1) WO2005058959A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
DK1937815T3 (da) 2005-09-13 2015-08-03 Nat Res Council Canada Fremgangsmåder og præparater til modulering af tumorcelleaktivitet
PL2085774T3 (pl) * 2008-02-01 2018-08-31 Kraft Foods R & D, Inc. Sposób określania konsystencji materiału spożywczego
WO2009102715A2 (en) * 2008-02-11 2009-08-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Peptide therapy for ocular herpes infections
WO2009101807A1 (ja) * 2008-02-14 2009-08-20 National University Corporation Kyoto Institute Of Technology ペプチド、当該ペプチドの用途及び生産方法並びに当該ペプチドが固定化された固相及びその生産方法
CA2928846A1 (en) 2009-11-24 2011-06-03 Alethia Biotherapeutics Inc. Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
US20120053128A1 (en) * 2010-08-26 2012-03-01 Xavier University Method of inhibiting angiogenesis
WO2013013187A1 (en) 2011-07-21 2013-01-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Apolipoprotein e polypeptides and their use
EA201491568A1 (ru) 2012-02-22 2014-11-28 Алетиа Байотерапьютикс Инк. Совместное применение ингибитора кластерина и ингибитора egfr для лечения рака
US9636299B2 (en) 2012-03-29 2017-05-02 Xavier University Of Louisiana Method for treating diabetic retinopathy
US20170298100A1 (en) * 2014-10-01 2017-10-19 Cascadia Life Sciences Llc Anti-viral peptides
JP2017530197A (ja) 2014-10-01 2017-10-12 プラント ヘルス ケア インコーポレイテッド 過敏感反応エリシターペプチド及びその使用
JP2017532981A (ja) 2014-10-01 2017-11-09 プラント ヘルス ケア インコーポレイテッド 破壊された過敏感反応ボックスを有するエリシターペプチド及びその使用
CN108883148A (zh) 2016-04-06 2018-11-23 植物保健公司 过敏反应激发子来源的肽及其用途
WO2017176588A1 (en) 2016-04-06 2017-10-12 Plant Health Care, Inc. Beneficial microbes for delivery of effector peptides or proteins and use thereof
EP3962925A4 (en) * 2019-04-30 2023-08-23 Maxwell Biosciences, Inc. HALOGENATED ANTIMICROBIAL PEPTOIDS
CN116813712B (zh) * 2023-06-16 2024-03-29 东北农业大学 一种富含Trp的α-螺旋结构抗菌肽W33及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
WO1999016460A2 (en) * 1997-09-30 1999-04-08 Duke University Apolipoprotein e/growth factor complexes and methods of use
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
GB0200757D0 (en) * 2002-01-15 2002-02-27 Univ Manchester Diagnostic methods
GB0329254D0 (en) * 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections

Also Published As

Publication number Publication date
EP1709075A2 (en) 2006-10-11
JP2007535910A (ja) 2007-12-13
GB0329254D0 (en) 2004-01-21
US7691382B2 (en) 2010-04-06
US20100221273A1 (en) 2010-09-02
JP2012115277A (ja) 2012-06-21
CN102336815A (zh) 2012-02-01
EP1709075B1 (en) 2012-06-06
CN1894281B (zh) 2012-10-03
WO2005058959A3 (en) 2005-12-15
US20130150288A1 (en) 2013-06-13
PL1709075T3 (pl) 2012-11-30
CN1894281A (zh) 2007-01-10
CA2548585A1 (en) 2005-06-30
ES2389078T3 (es) 2012-10-23
AU2004299343A1 (en) 2005-06-30
US20070117746A1 (en) 2007-05-24
EP1709075B9 (en) 2012-10-24
WO2005058959A2 (en) 2005-06-30
AU2004299343B8 (en) 2012-02-23
AU2004299343B2 (en) 2011-03-10
EP2277911A1 (en) 2011-01-26

Similar Documents

Publication Publication Date Title
DK1709075T3 (da) Behandling af virusinfektioner
DK1944322T3 (da) Behandling af TNFalfa-relaterede sygdomme
DK1755661T3 (da) Gelsolin til anvendelse til behandling af infektioner
IS8476A (is) Lifrarbólgu C-veirutálmar
IS8475A (is) Lifrarbólgu C-veirutálmar
DK1776136T3 (da) Behandling af tilstande, der involverer demyelinisering
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
FI20060154A (fi) Neurogeneratiivisten tilojen hoito
DK1501921T4 (da) Forbedrede virusrensningsmetoder
DK1653807T3 (da) Anvendelse af dermale mikroorganer
DK1744781T3 (da) Behandling af infektionssygdomme
DE602004018587D1 (de) Staubschützende Wegwerfmaske
DK1438306T3 (da) Derivater af UK-2A
IS7851A (is) 1-asýl-pýrrólídínafleiður til að meðhöndla veirusýkingar
DK1732604T3 (da) Fremgangsmåder til behandling af hiv-infektion
DK1765288T3 (da) Tobramycinpræparater til behandling af endobronchiale infektioner
DE602005012267D1 (de) N von geräten
DK1912996T3 (da) Makrocykliske inhibitorer af hepatitis C-virus
DK1912981T3 (da) Makrocykliske inhibitorer af Hepatitis C-virus
DK1912995T3 (da) Makrocykliske inhibitorer af hepatitis C virus
DK1587542T3 (da) Anvendelse af anti-CD100-antistoffer
MX266708B (es) Formulaciones de microparticulas de pantoprazol.
NO20053348D0 (no) Farmasoytisk sammensetning for behandling av virusangrep.
IS8399A (is) Form fjölgervings 3-fenýlsúlfónýl-8-píperasín-1-ýl-kínólíns
FI20030261A (fi) Iskulaite